Wall Street rebounds as Moderna and Merck cancer vaccine news lifts biotech

· Business USAJPNTWNBRA
This story has developed since this wire. Read the latest wire

Wall Street staged its strongest daily rebound since late May on Thursday after Moderna and Merck announced positive Phase 3 results for a personalized mRNA cancer vaccine, driving Moderna shares up 177% and Merck stock 13% higher.

The Dow Jones Industrial Average climbed 0.98% to 53,277, while the S&P 500 gained 0.43% and the Nasdaq Composite rose 0.43%. The rally came after Treasury Secretary Scott Bessent signaled readiness for more aggressive bond market intervention to contain borrowing costs.

The US national debt surpassed $40 trillion, adding fiscal pressure as uncertainty over US-Iran negotiations and the Strait of Hormuz standoff kept energy markets volatile. Tesla advanced after Nevada regulators approved robotaxi operations in parts of the state. Target reported second-quarter sales growth of 5.3%, while Fed minutes showed officials open to rate increases if inflation persists.

Story development

  1. Moderna cancer vaccine drives major index gains as Nvidia and OpenAI announce major deals
  2. Wall Street rebounds as Moderna and Merck cancer vaccine news lifts biotech

Related stories